Author Archive: AZBio
PERSONAL CARE PRODUCTS OFFER EXCITING NEW HOME-USE OPPORTUNITIES
Personal care products, that empower individuals, continue to be an exciting field within life sciences. Unlike data collection devices, such as Fitbit, personal care products use technology to solve medical or cosmetic needs at home. Examples of these types of products include technologies for microdermabrasion (PMD Microderm), laser hair removal (Tria), acne (Claro) and facial cleansing (Clarisonic). These types of technologies are only successful if users are convinced that they experience the desired result. New technologies and improved efficacy over the years has proven that many cosmetic healthcare needs are highly addressable with personal care devices.Continue reading
NCI releases Annual Plan and Budget Proposal
National Cancer Institute: Building on Opportunities in Cancer Research 2016 describes current opportunities to build on and advance cancer research.Continue reading
Capstone Therapeutics Announces Phase 1b/2a Study Results for AEM-28 Showing Safety and Biomarker Efficacy Signals
Capstone Therapeutics (OTCQB:CAPS) (“the Company”) and its joint venture affiliate, LipimetiX Development, LLC (“JV”), announced today the completion of and results for its investigational AEM-28 (Apo E mimetic peptide) Phase 1b/2a human clinical trial in cholesterol and lipid reduction.Continue reading
D3Bio launches to support the growth of Arizona Bioscience Innovation and Innovators from discovery to development to delivery.
For immediate release:
December 15, 2014 – Chandler, Ariz.
D3Bio, a collaboration between the Opportunity Through Entrepreneurship Foundation (OTEF), an Arizona 501c3 corporation, and the Arizona Bioindustry Association, Inc. (AZBio), officially launched at AZBio Trailblazers on December 11, 2014. D3Bio will operate as a division under OTEF to support Life Science Innovation and Life Science Innovators in Arizona and across the Rocky Mountain Southwest Region.Continue reading
CellTrust closes $10.5M Series A Growth Funding Led by Kayne Partners
CellTrust® Corporation, a global leader in collaborative secure mobile communication with tracing and archiving capabilities, announced today that it has closed $10.5M in Series A funding from Kayne Partners, the growth private equity group of Kayne Anderson Capital Advisors, L.P. The growth capital investment will enable CellTrust to keep pace with customer demand, extend its infrastructure and expand its team.Continue reading
VisionGate® Wins Two Gold Awards in the Best in Biz Awards 2014
VisionGate, Inc. has been named a gold winner in two categories in the Best in Biz Awards 2014, the only independent business awards program judged by members of the press and industry analysts. VisionGate was awarded gold in the Most Innovative Company of the Year (Small) category and in the Most Innovative Product of the Year (SMB) category.Continue reading
New TGen test uses the unique genetics of women to uncover neurologic disorders
Study published today by investigators with TGen’s Dorrance Center for Rare Childhood DisordersContinue reading
Biopharmaceutical Companies Reaffirm Commitment to Patients in Updated Principles
By Dr. Bill Chin, PhRMA
Researchers in biopharmaceutical companies strive to discover and develop new medicines and vaccines that will help people to live longer, healthier lives. They go to work every day knowing that patients with life-threatening diseases live with the hope that tomorrow will bring a new medicine that will extend and improve lives.Continue reading
Critical Path Institute Receives Third Grant to Accelerate Tuberculosis Diagnostics
Multi-year grant to fund innovative global data platform designed to streamline tuberculosis diagnosis and treatment